Eric Moschetta joined the Jones group in 2013 and worked on a number of collaborative projects within the Center exploring the adaptation of chemistries developed by CCHF scientists to being performed in flow reactors.
Working with the Davies group Eric help developed novel immobilization strategies for the dirhodium catalysts and designed and built flow reactors for these systems.
In 2016 Eric joined AbbVie in their Flow Chemistry Development section.